ArticleSmart molecules : open access2026
Beads-on-a-Tip testing for ultrasensitive antigen detection across a large dynamic range.
Article in Smart molecules : open access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lateral flow immunoassays (LFIAs) are low-cost, rapid, and easy to use for point-of-care testing (POCT), but the majority of the available LFIA tests are indicative, rather than quantitative, and their sensitivity in antigen tests are usually limited at the nanogram range, which is primarily due to the passive capillary fluidics through nitrocellulose membranes, often associated with non-specific bindings and high background noise. To overcome this challenge, we report a Beads-on-a-Tip design by replacing nitrocellulose membranes with a pipette tip loaded with magnetic beads. The beads are pre-conjugated with capture antibodies that support a typical sandwich immunoassay. This design enriches the low-abundant antigen proteins and allows an active washing process to significantly reduce non-specific bindings. To further improve the detection sensitivity, we employed upconversion nanoparticles (UCNPs) as luminescent reporters and SARS-CoV-2 spike (S) antigen as a model analyte to benchmark the performance of this design against our previously reported methods. We found that the key to enhance the immunocomplex formation and signal-to-noise ratio lay in optimizing incubation time and the UCNP-to-bead ratio. We therefore successfully demonstrated that the new method can achieve a very large dynamic range from 500 fg/mL to 10 μg/mL, across over 7 digits, and a limit of detection of 706 fg/mL, nearly another order of magnitude lower than the best reported LFIA using UCNPs in COVID-19 spike antigen detection. Our system offers a promising solution for ultra-sensitive and quantitative POCT diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.